US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 3, 2018 (8 years ago)

Capecitabine 150 mg Tablet NDC 00378-2511-91 28 days supply

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls.

What was recalled

Capecitabine 150 mg Tablet NDC 00378-2511-91 28 days supply

Recalling firm
Kroger Specialty Pharmacy, Inc.
NDC code
00378-2511-91
Origin
MS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0790-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Capecitabine recalls

See all
Class II · Moderate risk Terminated

Capecitabine tablets USP 500 mg

Reason Failed Dissolution Specifications: low test results at the 18 month time-point

Teva North America NDC 0093-7474-89 D-0732-2016
Class II · Moderate risk Terminated

Capecitabine Tablets

Reason Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.

Mylan Pharmaceuticals Inc NDC 0378-2512-78 D-1217-2015
Class II · Moderate risk Terminated

Capecitabine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-559-2015